Finance

Beta
Lists
EPGNF:OTCMKTS
Epigenomics AG
$1.12
0.00%
(0.00) 1D
Jul 18, 11:16:10 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EPGNF...
Mkt. cap
762.97K
Volume
0.00
52-wk high
$1.12
52-wk low
$0.95
Beta
50.83
Shares outstanding
877.00K
No. of employees
3
Mkt. cap
762.97K
Volume
0.00
52-wk high
$1.12
52-wk low
$0.95
Beta
50.83
Shares outstanding
877.00K
No. of employees
3
News stories
From sources across the web
Profile
Epigenomics AG is a molecular diagnostics company headquartered in Berlin, Germany with a wholly owned subsidiary, Epigenomics Inc. based in Seattle, WA. Wikipedia
About Epigenomics AG
CEOGregory Hamilton
Employees3
Founded1998
HeadquartersBerlin, Berlin, Germany
SectorBiotechnology
Websiteepigenomics.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
2.00K
2.00K
10.00K
10.00K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
25.00K
25.00K
31.50K
31.50K
Operating expense
115.50K
115.50K
87.50K
87.50K
Total operating expenses
115.50K
115.50K
87.50K
87.50K
Operating income
-113.50K
-113.50K
-77.50K
-77.50K
Other non operating income
500.00
500.00
-500.00
-500.00
EBT including unusual items
-102.00K
-102.00K
-55.00K
-55.00K
EBT excluding unusual items
-102.00K
-102.00K
-79.50K
-79.50K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
90.50K
90.50K
56.00K
56.00K
Net income
-102.00K
-102.00K
-55.00K
-55.00K
Net profit margin
-5,100.00%
-5,100.00%
-550.00%
-550.00%
Earnings per share
-
-
-
-
Interest and investment income
11.00K
11.00K
8.50K
8.50K
Interest expense
-
-
-
-
Net interest expenses
11.00K
11.00K
8.50K
8.50K
Depreciation and amortization charges
-
-
-
-
EBITDA
-110.50K
-110.50K
-74.50K
-74.50K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer